Q&A: The Bounce Back of Inergetics? Print E-mail
By M.E.Garza   

icon_ceoexclusiveThis past summer, Michael James was appointed to the CEO of Inergetics, Inc. (OTCBB: NRTI)- a leading developer of nutritional supplements for the Clinical Health and Sports Supplement markets. With a new team at the helm, is this penny stock firm finally ready to start delivering on its promise as a sports and health nutrition company?

Rising to the top of the world of nutritional supplements for the Clinical Health and Sports Supplement markets has proven to be tricky for a number of companies. After a couple of years trying to crack the code for success, the new leadership group at Inergetics- the developer of Surgex®; a sports nutrition formula designed  to meet the nutritional needs of professional, Olympic and amateur elite athletes that experience post-workout symptoms such as fatigue, loss of lean muscle, oxidative stress, and reduced immune function- finaly feels they have firm footing and a number of upcoming catalysts (including some merger and acquisition activity) that may help.

In addition, very recently, Dr. David L.Blecker MD., a leader in the nephrology space joined the firm's Advisory Board after seeing promising nutritional benefits from prescribing the drink formula to a limited number of dialysis patients. Blecker, who owns and operates a number of Dialysis units and is as partner in Regional Nephrology Associates is heading up a pre-marketing clinical study which may open up an entirely new and potentially lucrative market, for NRTI's line of Resurgex™ products-- which are designed to provide comprehensive nutritional support for actively treated cancer patients as well as those in post-treatment care and elderly members of the assisted living community.

A purely speculative penny stock play, the company finally feels they have positioned themselves as a "cleaned up candidate" which may finally start to realize some of the promise that James saw when he first invested some of his own money in the firm a number of years ago.

"It looks very positive, I'm the most excited I've been about the firm since I've been there," says James. "I went in as the cheif finaincial officer and we cleaned up a lot of the debt. We converted a lot of the debt into equity and now we have a marketing team who has done it before at two other companies- proven successfully... We've finally got the team in place to move together a build a business."


To learn more about Inergetics, visit www.inergetics.com, the Resurgex™ product website and online store, and www.resurgex.com, and the Surgex® product website and online store at www.surgexsports.com.

Disclosure: Long NRTI

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!